(Q39729927)

14 September 2017

title

Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer (English)

1 reference

14 September 2017

Li Pan

1

1 reference

14 September 2017

Xing-Chen Peng

2

1 reference

14 September 2017

Fei Leng

3

1 reference

14 September 2017

Qing-Zhong Yuan

4

1 reference

14 September 2017

Yan Shan

5

1 reference

14 September 2017

Dan-Dan Yu

6

1 reference

14 September 2017

Zhi-Yong Li

7

1 reference

14 September 2017

Xiang Chen

8

1 reference

14 September 2017

Wen-Jing Xiao

9

1 reference

14 September 2017

Yuan Wen

10

1 reference

14 September 2017

Tian-Tai Ma

11

1 reference

14 September 2017

Li Yang

12

1 reference

14 September 2017

Yong-Qiu Mao

13

1 reference

14 September 2017

Han-Shuo Yang

14

1 reference

14 September 2017

Yu-Quan Wei

15

1 reference

14 September 2017

Chun-Ting Wang

16

1 reference

14 September 2017

publication date

9 March 2010

1 reference

Journal of Cancer Research and Clinical Oncology

14 September 2017

published in

1 reference

14 September 2017

volume

137

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

19-28

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-010-0855-2

14 September 2017

exact match

0 references

cites work

Cancer gene therapy using a survivin mutant adenovirus

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-010-0855-2

Control of apoptosis during angiogenesis by survivin expression in endothelial cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-010-0855-2

A retrogen plasmid-based vaccine generates high titer antibody responses against the autologous cancer antigen survivin and demonstrates anti-tumor efficacy

21 January 2018

1 reference

12 December 2020

Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma

1 reference

12 December 2020

Survivin study: an update of "what is the next wave"?

1 reference

12 December 2020

Inhibition of melanoma tumor growth in vivo by survivin targeting

1 reference

12 December 2020

Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice

1 reference

12 December 2020

Dysregulation of apoptosis in cancer

1 reference

12 December 2020

Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis

1 reference

12 December 2020

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer

1 reference

12 December 2020

Survivin gene expression and prognosis in recurrent colorectal cancer

1 reference

12 December 2020

Cancer statistics, 2009

1 reference

12 December 2020

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells

1 reference

12 December 2020

Drug delivery systems: entering the mainstream

1 reference

12 December 2020

Cationic lipid vectors for plasmid DNA delivery

1 reference

12 December 2020

Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant

1 reference

12 December 2020

Target to apoptosis: a hopeful weapon for prostate cancer

1 reference

12 December 2020

Does resistance to apoptosis affect clinical response to antitumor drugs?

1 reference

12 December 2020

Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells

1 reference

12 December 2020

Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation

1 reference

12 December 2020

A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells

1 reference

12 December 2020

Full-length dominant-negative survivin for cancer immunotherapy.

1 reference

12 December 2020

IAP proteins: blocking the road to death's door

1 reference

12 December 2020

Role of the Survivin gene in pathophysiology

1 reference

12 December 2020

The molecular basis and potential role of survivin in cancer diagnosis and therapy

1 reference

12 December 2020

Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models

1 reference

12 December 2020

External beam radiotherapy for prostate cancer: current position and trends

1 reference

12 December 2020

Improved DNA: liposome complexes for increased systemic delivery and gene expression

1 reference

12 December 2020

If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells

1 reference

12 December 2020

Mechanisms and Functions of Cell Death

1 reference

12 December 2020

Targeting survivin in cancer therapy: fulfilled promises and open questions

1 reference

12 December 2020

Management of hormone refractory prostate cancer: current standards and future prospects

1 reference

12 December 2020

1 reference

12 December 2020

Expression of survivin and its relationship to loss of apoptosis in breast carcinomas

1 reference

12 December 2020

Apoptosis: mediator or mode of cell killing by anticancer agents?

1 reference

12 December 2020

Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.

1 reference

12 December 2020

Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas

1 reference

12 December 2020

Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy

1 reference

12 December 2020

Apoptosis is critical for drug response in vivo

1 reference

12 December 2020

Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy

1 reference

12 December 2020

Prostate cancer. Primary hormonal treatment

1 reference

12 December 2020

A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication

1 reference

12 December 2020

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

12 December 2020

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

1 reference

12 December 2020

Permanent prostate brachytherapy: a century of technical evolution

1 reference

12 December 2020

10.1007/S00432-010-0855-2

Identifiers

DOI

1 reference

14 September 2017

1 reference